Loading paragraph...
Today's Biggest Stock Gainers
| Symbol | Name | Last Price | Change | % Change | Volume | Market Cap | 52-Week Range |
|---|---|---|---|---|---|---|---|
| CDTX | Cidara Therapeutics | $218.09 | $112.10 | 105.77% | 13.8M | $3.3B | $13.90$218.85 |
| CYCU | Cycurion | $5.68 | $1.50 | 35.94% | 11.5M | $12.1M | $2.15$2,045.10 |
| IVVD | Invivyd | $2.41 | $0.64 | 35.88% | 4.3M | $412.6M | $0.35$2.75 |
| TOI | Oncology Institute | $3.94 | $0.86 | 27.92% | 6.9M | $288.0M | $0.13$4.88 |
| PGEN | Precigen | $4.90 | $1.04 | 26.94% | 11.7M | $1.2B | $0.65$5.23 |
| DRIO | DarioHealth | $12.39 | $2.47 | 24.90% | 36.8K | $67.1M | $5.94$31.00 |
| SRRK | Scholar Rock | $37.06 | $6.99 | 23.25% | 4.4M | $2.9B | $22.71$46.98 |
| OMER | Omeros | $7.74 | $1.46 | 23.23% | 3.7M | $427.4M | $2.95$13.60 |
| AIRG | Airgain | $3.78 | $0.71 | 23.10% | 209.7K | $36.5M | $3.00$9.65 |
| AVDL | Avadel Pharmaceuticals Plc | $23.30 | $4.06 | 21.08% | 9.8M | $1.9B | $6.38$23.40 |
Related Articles
Featured Article
This Healthcare Stock Is Up 1,000%, Outpacing Nvidia, Tesla, and Apple Combined
Lawrence Rothman|Oct 21, 2025
Can Oncology Institute's stock continue rewarding investors?
A Deal With Novo Nordisk Sent This Stock 181% Higher Overnight. Is It a Buy Now?
Cory Renauer|Oct 16, 2025
Find out if the deal Omeros announced is enough of a reason to buy this stock.
These 2 Healthcare Stocks More Than Doubled Recently and Could Soar Higher, According to Wall Street Analysts
Cory Renauer|Sep 7, 2025
Experts who follow these stocks think they can fly higher despite already gaining over 100% since the end of July.
Here's Why Everybody's Talking About Scholar Rock Right Now
Cory Renauer|Oct 9, 2024
Successful clinical-trial results recently made Scholar Rock one of the stock market's top performers.
Bargain Hunting: 2 Top Stocks to Buy Before 2025
Matt Frankel and Tyler Crowe|Sep 7, 2024
There are some cheap stocks in the market, and here are two in particular that could be worth a closer look.
Invivyd Stock More Than Doubled Last Week. Is It Too Late to Buy?
Cory Renauer|Dec 23, 2023
The clinical-stage biotech delivered positive trial results for its new COVID-19 preventative antibody treatment.
This $1.1 Trillion Industry Could Be Worth $3.8 Trillion by 2030: 3 Stocks Set to Skyrocket
Matt DiLallo, Tyler Crowe, and Jason Hall|Oct 22, 2023
These companies are in prime positions to capitalize on the massive and growing renewable energy market.
Bargain Hunting in Energy Stocks: 2 Renewable Stocks on Sale Right Now
Jason Hall and Tyler Crowe|Jul 2, 2023
These two are underappreciated gems.
These 2 Stocks Are Having Their Day in the Sun
Dan Caplinger|Mar 21, 2023
Markets opened higher on high hopes for a recovery from banking challenges.
2 Unmatched Stocks Wall Street Thinks Will Soar 152% or More in the Next 2 Years
Alex Carchidi|Mar 17, 2023
Biotechs are capable of making huge gains in short periods, and they often do.
